Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependant lung carcinomas

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependant lung carcinomas. Journal of Clinical Investigation. 2007; 117(2):346-52.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.